Bahala, Charlize Gilliane .
HRN: 24-29-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2024
CO-AMOXICLAV 625MG (TAB)
01/04/2024
01/09/2024
PO
1 Tab
BID
Perineal Swelling
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes